Proof of Concept Study of Cognitive Improvement in Patients With Schizophrenia
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate that AZD3480 improves cognition in patients with
stable schizophrenia who are being treated with an atypical antipsychotic and who are active
cigarette smokers, to assess the safety and tolerability of AZD3480 and to define the optimal
dose(s) to be used in future trials.